| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer KP Olive, MA Jacobetz, CJ Davidson, A Gopinathan, D McIntyre, ... Science 324 (5933), 1457-1461, 2009 | 3527 | 2009 |
| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3162 | 2016 |
| Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 2618 | 2015 |
| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1822 | 2018 |
| DNA methylation biomarkers for blood-based colorectal cancer screening C Lofton-Day, F Model, T DeVos, R Tetzner, J Distler, M Schuster, X Song, ... Clinical chemistry 54 (2), 414-423, 2008 | 593 | 2008 |
| Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer T Devos, R Tetzner, F Model, G Weiss, M Schuster, J Distler, KV Steiger, ... Clinical chemistry 55 (7), 1337-1346, 2009 | 592 | 2009 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 537* | 2021 |
| Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay R Grützmann, B Molnar, C Pilarsky, JK Habermann, PM Schlag, ... PloS one 3 (11), e3759, 2008 | 464 | 2008 |
| Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer S Hinz, L Pagerols-Raluy, HH Oberg, O Ammerpohl, S Grüssel, B Sipos, ... Cancer research 67 (17), 8344-8350, 2007 | 456 | 2007 |
| Chemoresistance in pancreatic cancer S Zeng, M Pöttler, B Lan, R Grützmann, C Pilarsky, H Yang International journal of molecular sciences 20 (18), 4504, 2019 | 444 | 2019 |
| Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ... Journal of Clinical Oncology 37 (34), 3212-3222, 2019 | 408 | 2019 |
| Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data C Pilarsky, M Wenzig, T Specht, HD Saeger, R Grützmann Neoplasia 6 (6), 744-750, 2004 | 405 | 2004 |
| The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ... Nature 486 (7402), 266-270, 2012 | 343 | 2012 |
| Neuroendocrine tumors of the pancreas F Ehehalt, HD Saeger, CM Schmidt, R Grützmann The oncologist 14 (5), 456-467, 2009 | 341 | 2009 |
| Variants in CPA1 are strongly associated with early onset chronic pancreatitis H Witt, S Beer, J Rosendahl, JM Chen, GR Chandak, A Masamune, ... Nature genetics 45 (10), 1216-1220, 2013 | 328 | 2013 |
| Effect of hospital volume on in-hospital morbidity and mortality following pancreatic surgery in Germany C Krautz, U Nimptsch, GF Weber, T Mansky, R Grützmann Annals of surgery 267 (3), 411-417, 2018 | 276 | 2018 |
| Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN M Distler, D Aust, J Weitz, C Pilarsky, R Grützmann BioMed research international 2014, 2014 | 273 | 2014 |
| CONKO-005: adjuvant chemotherapy with gemcitabine plus erlotinib versus gemcitabine alone in patients after R0 resection of pancreatic cancer: a multicenter randomized phase … M Sinn, M Bahra, T Liersch, K Gellert, H Messmann, W Bechstein, ... Journal of Clinical Oncology 35 (29), 3330-3337, 2017 | 269 | 2017 |
| Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays R Grützmann, C Pilarsky, O Ammerpohl, J Luttges, A Böhme, B Sipos, ... Neoplasia 6 (5), 611-622, 2004 | 249 | 2004 |
| Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis J Mayerle, H Kalthoff, R Reszka, B Kamlage, E Peter, B Schniewind, ... Gut 67 (1), 128-137, 2018 | 246 | 2018 |
